Table 3.
The baseline data.
| Variable | COVID-19 group, N = 45 | Control group, N = 45 | P value | |
|---|---|---|---|---|
| Agea (years) | 63 (53–68) | 61 (54–67) | 0.897 | |
| Gender (female)c | 21 (47) | 22 (49) | 1.00 | |
|
| ||||
| Comorbiditiesc | (i) DM | 16 (36) | 12 (27) | 0.495 |
| (ii) Malignancy | 3 (7) | 5 (11) | 0.714 | |
| (iii) Cardiovascular diseases | 4 (9) | 6 (13) | 0.739 | |
|
| ||||
| Laboratory data | Lymphocytic countb (μl) | 1.16 ± 0.49 | ||
| CRPa (mg/L) | 37 (24–68) | |||
| D-dimera (mg/L) | 0.68 (0.38–1.08) | |||
|
| ||||
| Oxygen saturationb (%) | 81.2 ± 9.4 | |||
aData were expressed as median and IQ. bData were expressed as mean ± SD. cData were expressed as n and %.